Lodestone Wealth Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Lodestone Wealth Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,304	Closed	-$230K	–	150
2024 Q2	$230K	Sell	8,304 -123	-1%	-$2.88K	0.12%	139
2024 Q1	$236K	Sell	8,427 -926	-10%	-$21.7K	0.12%	141
2023 Q4	$262K	Sell	9,353 -719	-7%	-$14.4K	0.15%	128
2023 Q3	$256K	Sell	10,072 -2,681	-21%	-$60.2K	0.18%	115
2023 Q2	$336K	Buy	+12,753	New	+$306K	0.23%	102

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

CCA

Cora Capital Advisors Marlton, New Jersey $302M AUM 16.46% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Lodestone Wealth Management's IDNA Position: Q3 2024 in Review

Lodestone Wealth Management sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2024, closing a stake of 8,304 shares — an estimated $230K sold.

Lodestone Wealth Management first reported a position in IDNA in Q2 2023 and held it in 5 quarters. The position peaked at $336K in Q2 2023. 53 funds tracked by Wall St. Rank hold IDNA as of Q3 2024.

Lodestone Wealth Management reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2024 after selling out during the quarter.
Lodestone Wealth Management sold 8,304 iShares Genomics Immunology and Healthcare ETF shares in Q3 2024, an estimated $230K.
Lodestone Wealth Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2023 and held it in 5 quarters.
Lodestone Wealth Management's iShares Genomics Immunology and Healthcare ETF position peaked at $336K in Q2 2023.
53 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2024.

Based on Lodestone Wealth Management's 13F filing for Q3 2024, filed 29 Oct 2024.